T he retina's unique histologic, metabolic, and physiological characteristics are, in large part, due to its distinctive gene expression profile. Studies of genes that are preferentially expressed in the retina (retina-enriched genes) have provided important insights into processes such as phototransduction and the visual cycle, and into photoreceptor structure. The crucial role of such genes is underscored by the fact that approximately half of all retinal degeneration-associated genes identified to date are preferentially expressed in the retina. 1 In an effort to learn more about retinal function and disease, identification of additional retina-enriched genes has become a major focus in recent years. [1] [2] [3] [4] [5] [6] [7] [8] These efforts are being aided by advances in the human genome project combined with the development of high-throughput gene expression profiling approaches that facilitate the simultaneous identification of multiple tissue-specific genes. 9 Sequencing and data mining of cDNA libraries is one of the high-throughput expression profiling approaches that has been applied to identify retina-enriched genes. 4 -8 However, potential bias and limited cost effectiveness has hampered its application for gene expression level comparison across multiple samples. 10 Two additional recent techniques, serial analyses of gene expression (SAGE) and microarrays, have gained popularity for high-throughput gene expression profiling. [11] [12] [13] Both methods have been efficient in identifying novel genes and in providing insights into complex pathologic processes, such as cancer and disease of the central nervous system. 14, 15 Unlike microarrays, SAGE is not dependent on preselection of sequences for analysis. It theoretically can identify all mRNA molecules in a sample. In practice, however, SAGE is often limited by the presence of orphan and ambiguous tags and by the considerable sequencing costs involved in its application for the study of multiple samples. By contrast, microarrays can be more readily applied to analyses of multiple samples, and follow-up studies on particular sequences are simplified by the immediate availability of the relevant cDNA clones. In contrast to SAGE, a disadvantage of microarrays is that they are limited to analyses of the sequences represented on the array. This limitation is particularly problematic when studying highly specialized tissues such as the retina, because the differentially expressed genes that underlie the unique structure and function of the retina are underrepresented on commercial microarrays.
One approach to circumvent this problem of limited representation of genes of importance to the retina is to construct custom cDNA microarrays enriched for genes that are likely to be relevant for retinal research. Recently, the feasibility of constructing a mouse retina custom cDNA microarray was reported. 16, 17 Herein, we report construction of a custom human cDNA microarray that allows for comprehensive expression profiling of genes that are likely to be of interest in studies of the normal and diseased human retina. As one potential application of this microarray, we describe its use to identify human genes with a retina-enriched expression pattern.
METHODS

Generation of PCR Products
We were able to obtain clones representing 10,034 of the 12,000 genes and ESTs included in our gene list (see the Results section for details about the generation of the gene list). Approximately 6,000 of the clones were obtained from the sequence verified 40,000-clone set from Research Genetics (Invitrogen Life Technologies, Carlsbad, CA). Clones were also amplified from two arrayed retina cDNA library sets: Soares (University of Iowa Health Care, Iowa City, IA) N2b4HR retina library (Unigene library number 178; http://www.ncbi.nlm.nih.gov/ UniGene; provided in the public domain by the National Center for Biotechnology Information [NCBI], Bethesda, MD), roughly 1500 clones, and a library generated and arrayed by Jeremy Nathans and Amir Rattner (NCBI Unigene library number 226 and 228), approximately 2000 clones. Five hundred additional clones, most of which were sequence verified, that were not found in these sources were purchased individually from Research Genetics. Bacterial clones were rearrayed and cultured for 12 hours at 37°C in 96-well plates containing Luria-Bertani [LB] medium/10% glycerol. Plates were then stored at Ϫ80°C. Products for spotting were generated by PCR amplification. A disposable 96-pin replicator was used to add small aliquots from the bacterial growth plates directly to duplicate 96-well PCR plates, with each well containing 100 L of reaction mix composed of primers M13AEK forward and reverse for the Research Genetics and Soares retina library clones (ctgcaaggcgattaagttgggtaac and gtgagcggataacaatttcacacaggaaacagc), or GT Ϫ10 forward and reverse (ggttaagtccaagctgaattc and gggtaaaaagcaaaagaattc) for Nathans's and Rattner's retina library, and Taq polymerase (Invitrogen). The resultant duplicate PCR products were combined, purified (MultiScreen; Millipore, Bedford, MA), and resuspended in 50 L of Tris-EDTA. PCR product concentration after resuspension ranged from 100 to 1000 ng/L. A sample from each PCR product was evaluated by gel electrophoresis. The overall PCR success rate was 95%. The purified PCR products were then dried, resuspended in 50% dimethyl sulfoxide (DMSO), and arrayed in 384-well plates.
Probe Labeling
Probes were prepared by minor modification of the method described by Hedge et al. 18 RNA was extracted using isolation reagent (TRIzol; Invitrogen) according to the manufacturer's protocol, and 20-g aliquots of total RNA were treated with DNase (DNAfree; Ambion, Austin, TX), followed by RNA purification (RNeasy kit; Qiagen, Valencia, CA). Purified RNA samples were then incubated for 10 minutes at 70°C with 6 g random hexamers (Invitrogen), cooled on ice, and used as a template for first-strand cDNA synthesis (5 L first-strand buffer, 3 L dithiothreitol [DTT], 2 L reverse transcriptase (SuperScript II; Invitrogen) and 0.6 L of a mixture of 10 mM aminoallyl-UTP (Sigma-Aldrich Corp., St. Louis, MO), 15 mM dTTP and 25 mM of dATP, dCTP, and dGTP (Invitrogen)). The 30-L reverse transcription reaction was incubated overnight at 42°C. The 2:3 aminoallyl-UTP to dTTP ratio used in the RT reaction was selected after testing various ratios. For human RNA, the 2:3 ratio yielded the best results in terms of dye incorporation and hybridization (data not shown). After the RT reaction, 10 L 1 M NaOH and 10 L 0.5 M EDTA (pH 8) were added. After incubation for 15 minutes at 65°C, 25 L of Tris-HCl (pH 7.4) was added followed by a purification step (PCR purification kit; Qiagen) in which the PE wash buffer in the kit was replaced with a phosphate wash buffer (1 M KPO 4 [pH 8] in 80% ethanol).
The purified cDNA was dried, resuspended in 4.5 L of 0.1 M carbonate buffer (pH 9), and incubated for 2 hours in room temperature with 12.3 g of either Cy3 or Cy5 monoreactive dye (Amersham Biosciences, Inc., Piscataway, NJ) suspended in 4.5 L of DMSO. The labeled probe was then purified (PCR purification kit; Qiagen) and dried in a heated speed vac. The total amount of dye incorporation (measured in picomoles of dye per probe) and the ratio of unlabeled to fluorescent labeled nucleotide in the probe were assessed by measuring probe absorbance at 260, 550, and 650 nm to assess DNA, Cy3, and Cy5 concentration, respectively. 18 In typical reactions, dye incorporation is more than 300 picomoles and the unlabeled/labeled nucleotide ratio is in the range of 10 to 20.
Slide Printing, Postprocessing, and Hybridization
Amine-coated slides (SuperAmine; TeleChem, Sunnyvale, CA) were printed using an arrayer with 100-m-tip pins (MicroGrid II; Biorobotics, Cambridge, UK) in a 60% humidity and 22°C environment. Slides were stored in a desiccator for up to 6 months and treated with 60 mJ of UV light (UV Stratalinker 2400; Stratagene, La Jolla, CA) before use.
Prehybridization and hybridization were preformed as described by Hedge et al. 18 Briefly, slides were incubated for 40 minutes in 1% bovine serum albumin (BSA), 5ϫ SSC, and 0.1% SDS at 42°C, washed in water and isopropanol, and dried using compressed air. Cy3 and Cy5 labeled probes were combined in 40 L hybridization buffer (50% formamide, 5ϫ SSC, 0.1% SDS buffer, 10 g poly dA, and 10 g Cot-1 DNA) and heated at 95°C for 3 minutes. Hybridization was performed under a coverslip (Fisher Scientific, Suwanee, GA) in a humidified hybridization chamber (GeneMachine, San Carlos, CA) for 18 hours in a water bath at 42°C. After hybridization, slides were washed in 1ϫ SSC/0.2% SDS at 42°C, followed by washes in 0.1ϫ SSC/0.2% SDS, and 0.1ϫ SSC both at room temperature. Each wash lasted for 4 minutes, and then the slides were dried with compressed air.
Data Acquisition and Analysis
Slides were scanned using the a confocal laser scanner (ScanArray 5000; Perkin Elmer, Boston, MA). Scans using the maximum laser power setting that did not produce saturated spots were used for analyses. Spot finding and quantification of fluorescence intensity were performed on computer (Imagene software; Biodiscovery, Inc., Marina del Rey, CA). Local background subtraction and normalization were also performed on computer (Genesight software; Biodiscovery, Inc.) by dividing each spot intensity by the mean intensity value of that particular fluorescent channel (either Cy3 or Cy5).
Normalized study sample-reference sample ratios were analyzed using the significant analyses for microarray (SAM) algorithm. 19 Twoclass unpaired analysis was applied to compare the five retina samples to the liver and cortex samples separately. SAM calculates a false discovery rate (FDR), which is the median percentage of genes from a list that are likely to be mistakenly identified as differentially expressed. According to the SAM algorithm, genes are identified as differentially expressed based on the difference in expression among the sample groups and the consistency of this expression difference. We used similar, but not identical, FDRs to identify common genes in the retina-cortex and retina-liver expression pattern comparisons, because the SAM algorithm does not produce continuous FDR values but rather produces increments that depend on the imputed data.
In this study novel genes were defined as EST or group of ESTs that are not part of a cloned gene, regardless of whether the EST was assigned to a Unigene cluster.
Hierarchical clustering was performed and viewed using the Cluster and Treeview (both softwares are available at http://rna.lbl.gov. Eisensoftware.htm; softwares were developed by M. Eisen and provided in the public domain by the Lawrence Berkeley National lab and the University of California at Berkeley, Berkeley, CA) programs, respectively. 20 Principal component analyses (PCAs) were performed on computer (Partek; Partek Inc., St. Charles, MO). Assessment of the tissue distribution of the expressed sequences was performed by BLAST search of each sequence against the human EST database (http://www.ncbi.nlm.nih.gov/dbest/ NCBI, Bethesda, MD). Hits with an E-value less than 1 eϪ10 were accepted and mapped to the library name and further to the tissue of origin (http://www.ncbi.nlm.nih .gov/UniLib). For each clone the number of unique tissues in which matches were found were counted.
Donor Tissue
Five eyes were obtained through the National Disease Research Interchange (NDRI, Philadelphia, PA). Whole retinas were dissected and RNA extracted as described under probe labeling. RNA was also extracted from two liver and cortex tissues that were obtained from three donors (Table 1) .
Quantitative Real-Time PCR
The expression levels of 11 genes and ESTs identified as retina-enriched according to the array experiments were studied by real-time PCR to validate the microarray results. RNA was DNase treated (DNAfree; Ambion), and cDNA was synthesized from 1 g of retinal, liver, and cortex RNA (retina 5 and liver and cortex 1 in Table 1 ), using commercial reverse transcriptase (Superscript II; Invitrogen). Control reactions without addition of RT enzyme were performed with each cDNA synthesis, and aliquots from these tubes were tested by PCR to ascertain the absence of DNA contamination. Primers used are listed in Web Table 2 accessible online at http://www.iovs.org/cgi/content/ full/44/9/3732/DC1. Real time PCR reactions were performed using a PCR cycler (Light-Cycler; Roche, Nutley, NJ). Six serial twofold dilutions of the retina sample were defined as standard in all the reactions. PCR products were quantified using the second derivate maximum values calculated by the system's analysis software (Roche). Expression levels were normalized to the acidic ribosomal phosphoprotein P0 (ARP) mRNA levels. 21 Each EST was tested in duplicate PCR reactions, and the mean of the two reactions was used for calculating the expression levels. FIGURE 1. Classification of the gene set represented on the array (ᮀ), and retina-enriched genes compared with cortex (z; FDR ϭ 26%) and liver (s; FDR ϭ 27%), based on biological (A) and molecular (B) function. Gene function was classified based on the gene ontology database (http://www.geneontology.org/). Only those genes that were present in the gene ontology database were classified. In (A), the number of genes classified from the array, retina-cortex, and retinaliver comparisons was 1106, 49, and 86, respectively. In (B), the number of genes classified from the array, retina-cortex, and retinaliver comparisons was 2098, 71, and 177, respectively. As indicated, the known photoreceptor gene set is enriched for genes that are differentially expressed in the retina, whereas the inflammation and immune response categories are deficient in such differentially expressed genes.
FIGURE 2.
Scattergram showing self-self hybridization to human retinal microarray. A 40-g reference RNA sample was divided into equal aliquots, one of which was labeled with Cy3 (x-axis), whereas the other was labeled with Cy5 (y-axis). Each axis shows the normalized expression level expressed in log base 2. The correlation coefficient is shown. 
RESULTS
Microarray Design, Optimization, and Validation
The first criterion we used for selection of genes to be included in the human retinal cDNA microarray was expression pattern-specifically, representation in a human retina and/or retinal pigment epithelium (RPE) cDNA library. We were able to obtain plasmids representing 10,034 of the sequences on our master list. Of these, 67% are from known genes and 33% are from ESTs. About half of the known genes on the array have been characterized. Their encoded proteins are involved in variety of biological (Fig. 1A) and molecular (Fig. 1B) processes.
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After generating and purifying PCR products representing the 10,034 cDNAs, we tested various conditions for spotting and hybridization, and obtained stronger and more consistent signals using 50% DMSO compared with aqueous spotting buffers (data not shown). cDNA labeling methods were also optimized and compared. We found that the indirect method (with aminoallyl-UTP), compared with direct dye incorporation, was superior in terms of amount of dye incorporated per probe as well as the ratio of labeled/unlabeled nucleotide in the probe, and yielded higher signal-to-noise ratios on hybridization (data not shown). In addition, indirect labeling yielded similar incorporation of Cy3 and Cy5, whereas with the direct method Cy5 incorporation was significantly less than that of Cy3.
To assess overall performance and reliability of our microarray analyses, we performed self-self hybridizations. Forty micrograms of reference sample total RNA was divided into two aliquots: Half was labeled with Cy3, and the other half was labeled with Cy5, and then the two were mixed and hybridized together (Fig. 2) . A high degree of correlation was achieved between the two channels (correlation coefficient, R 2 ϭ 0.9432), demonstrating the reproducibility of the labeling, hybridization, and image analysis processes. However, it should be noted that a small fraction of the genes artifactually appeared to be differentially expressed: 21 of the 10,034 sequences showed twofold expression difference in the hybridization presented in Figure 2 . This is a common finding in microarray studies that underscores the importance of performing replicate arrays with dye swapping for each sample. The signal-to-background ratios varied across the spots on each slide and across arrays, with average signal-to-background ratios of the Cy3 and Cy5 channels on different slides varying from 2 Ϯ 1.9 to 9.8 Ϯ 6.7, and the percentage of spots with signal-to-background ratios higher than 1.4-fold varied from 36% to 85%.
Identifying Retina-Enriched Genes
The custom microarray was then used to identify retina-enriched genes by comparing the expression profile of retina to that of brain (cortex) and liver. Analysis of each tissue was performed with at least two donors to decrease bias that may be introduced by donor-specific gene expression patterns. A reference experimental design was used; retina (n ϭ 5), liver (n ϭ 2) and cortex (n ϭ 2) RNA samples were studied in duplicate with two microarray slides for each sample (total of 18 microarrays). In the first hybridization, the study sample was labeled with Cy3 and a human reference sample composed of 80% cortex RNA, 15% retina RNA and 5% retinal pigment epithelium RNA was labeled with Cy5. In the second hybridization, dyes were swapped between the study and the reference samples. This design enables comparison across all samples (by using a common reference sample) and corrects for possible differential effects of Cy3 and Cy5 dye on labeling and hybridization.
As would be expected based on their shared neuronal identity, the expression pattern of the retina was more similar to that of cortex than that of liver. This was reflected by the finding that, at similar significance levels, more than twice as many genes were preferentially expressed in the retina compared with liver than in the retina compared with cortex based on the SAM algorithm (Web Tables 3 and 4 are accessible at http://www.iovs.org/cgi/content/full/44/9/3732/DC1). As outlined in the Methods section, we have assessed the statistical significance of the differential gene expression patterns by using the FDR as determined with the SAM algorithm. 19 The FDR is the median number of genes likely to be falsely identified as differentially expressed between samples. For example, at a moderately stringent FDR of 26% for the retina-cortex and 27% for the retina-liver comparisons (the design of the SAM program makes it difficult to achieve identical FDRs), there were 452 and 1097 genes that were preferentially expressed in the retina in the retina-cortex and retina-liver comparison, respectively (Web Tables 3 and 4 ). Fig. 1 shows the functional annotation of genes from Web Tables 3 and 4. Known photoreceptor genes, which constitute the best-defined group of retina-specific genes, composed a larger portion of the identified retina-enriched genes from the retina-cortex versus retina-liver comparison (46% vs. 26%, respectively; Fig. 1 ). In contrast, a larger absolute number of known photoreceptor genes were correctly identified by the retina-liver versus the retina-cortex comparison (31 vs. 25 genes, respectively). These findings presumably stem from the higher retina-cortex than retina-liver similarity and reflect better specificity for the FIGURE 3. Classification of retina-enriched genes common to retinacortex and retina-liver comparison at false discovery rates of 10.3% and 9.5%, respectively (total of 224 sequences which are listed in Table  5 and Web Table 5 ). Hierarchical clustering (A, B) and PCA (C, D) of the individual retina, cortex, and liver samples. Cluster analysis was performed with the program Cluster, using average linkage clustering of all genes with more than 80% of values present and with at least one of the expression ratios having a value greater than 1.4. Analyses were performed with both the full set of genes on the array (A, C) and with the subset of retina-enriched genes (B, D). Difference in expression profile between samples is represented by branch length in (A) and (B), and by distance in space between samples in (C) and (D). In (C) and (D): retina (OE), cortex (F), liver (f). With both hierarchical clustering and PCA, the separation of the retina samples from the other samples is clearer when the analysis is restricted to the retina-enriched gene subset.
FIGURE 4.
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Novel Genes Preferentially Expressed in the Retina 3737 retina-cortex comparison, and better sensitivity for the retinaliver comparison for identifying retina-specific genes. Of note, both inflammation and immune response genes were rare or absent among the retina-enriched genes compared with their significant representation among the sequences on the array (Fig. 1) , perhaps reflecting the so-called immune-privileged status of the retina. To focus more on individual differentially expressed genes, so as to select genes of potential interest for further evaluation, we reanalyzed the data with a more stringent FDR. With FDRs of 10.3% and 9.5% for the retina-cortex and retina-liver comparisons, 345 and 720 retina-enriched genes were identified, respectively. Of these genes, 211 were common to both lists (Table 5 lists the top 40 of these genes; the full list is available in Web Table 5 at http://www.iovs.org/cgi/content/full/44/9/ 3732/DC1). Of these, 46% (98 genes) were ESTs representing novel retina-enriched genes, and 36% (77 genes) and 17% (36 genes) were cloned genes with known or unknown function, respectively. Of those with known function, 32% (25 genes) represent already characterized photoreceptor-enriched or photoreceptor-specific genes (Fig. 3) , compared with 10% percent of known photoreceptor-enriched genes of the genes with known function on the array (Fig. 1) . This was a reassuring finding and suggests that a significant fraction of the remaining 186 genes in the group (Table 5 ) are likely to represent retina-enriched genes.
The gene expression patterns identified by the microarray studies were also analyzed by both hierarchical clustering and principle component analysis (PCA) to ascertain the consistency of the observed tissue-specific expression patterns identified by the array experiment (Fig. 4) . When all sequences on the array were used for clustering, the five retina samples clustered together and were distinct from both the cortex and the liver. When only the retina-enriched genes set identified by the SAM analysis (Table 5) was used for clustering, the overall pattern was similar, but the retinas were more separated from the cortex and liver samples. This is apparent by the longer branches that separate the retina samples from the cortex and liver samples in the hierarchical clustering (Figs. 4A, 4B) . The liver and cortex samples cluster together, probably reflecting the bias of our microarray toward retina-enriched genes, which masks the differences between cortex and liver gene expression. Furthermore, the overwhelmingly different gene expression pattern of the retina versus cortex and liver observed our custom retina array also probably results in blunting of the closer similarity of the retina-cortex expression pattern compared with the retina-liver expression pattern that was obvious with the SAM analyses. PCA results were consistent with the hierarchical clustering (Figs. 4C, 4D) . Again, retina samples segregated more closely together and further from the liver and cortex samples when only retina-enriched genes as opposed to all genes on the array were used for clustering: The mean retina-cortex and retina-liver distance by PCA were 0.84 and 0.72, respectively, when all genes were used for clustering. When only retina-enriched genes were used, the mean retinacortex and retina-liver distances were 2.1 and 2.5, respectively.
As a complementary approach to assessing the expression pattern of the genes identified as retina-enriched by the array analysis, we determined the distribution pattern of each identified gene in tissue EST libraries available at NCBI. As a summary value, we counted how many different tissue libraries contained a representative of each microarray-identified gene. We compared the distribution pattern of the sequences identified as retina-enriched to that of 1000 randomly selected sequences from the array and to that of 1000 randomly selected sequences from the human genome. The analysis showed that approximately 38% of the retina-enriched genes were identified only in one tissue (Web Table 6 , accessible at http://www.iovs.org/cgi/content/full/44/9/3732/DC1, shows the library distribution of the full set of retina-enriched genes). Thirteen of the 35 sequences that were present in two tissues were found only in the central nervous tissue in addition to the eye. By comparison, approximately 7% of the sequences in the genome were cloned from a single tissue (not necessarily retina). Most of the retina-enriched genes were expressed in several different tissues. Approximately 25% of such genes (compared with 64% of the randomly selected genes from the human genome) are expressed in more than 10 tissues (Fig. 5) . The total set of genes represented on the retina custom array showed corresponding values between the retina-enriched gene and the randomly selected gene sets, presumably reflecting the selection bias used in generating the retina array (Fig. 5) .
To validate our microarray results using an independent experimental method, the retina-enriched expression pattern of 11 of the retina-enriched genes and ESTs was studied by quantitative real-time RT-PCR (QPCR) on one of the retina samples (retina 5). The differential expression pattern of all 11 genes was confirmed, but as noted previously, 22,23 the expression ratio obtained by array analysis often underestimated that obtained by QPCR. For the 11 genes and ESTs studied, the array analysis indicated retina-enriched expression ratios of 2.3-to 24.8-fold, whereas the QPCR results indicated ratios of 1.4-to 7023-fold ( Table 7) .
Comparison of High-Throughput Retinal Gene Expression Studies
To assess the similarities and differences between the various approaches that are being used to profile retinal gene expression patterns, we compared our results with those of two recent SAGE studies, one of mouse 1 and one of human retina, 3 and another study based on EST data mining. 4 The comparison served to validate the identification of novel retina-enriched genes by each of the studies, as a number of genes were found in common, but also revealed significant differences between the approaches, probably reflecting both different experimental design and technical issues.
We included in the analysis the genes from the retinacortex comparison at an FDR of 26% (Web Table 3 in the present study), genes in Table S11 from Blackshaw et al., 1 genes in Table 11 from Sharon et al., 3 and genes in Table 2 FIGURE 5. Expression pattern of retina-enriched genes, microarray gene set, and random ESTs, as assessed by a bioinformatic analysis of representation in ESTs tissue libraries. Analysis was performed as described in the text. The x-axis is the number of tissues from which a sequence identical with the one that was submitted for a BLAST search was cloned. The y-axis represents the fraction of sequences in each of the three groups (random ESTs ᮀ; retina custom array z; and retina-enriched genes s) that were found in each number of tissues.
The microarray-defined retina-enriched genes, as would be expected, are overrepresented in the subsets of genes that are found in only one or two tissue libraries, and are underrepresented in the subsets that are found in more than 10 tissue libraries.
from Stohr et al. 4 In all cases the genes from these tables were identified by the authors as retina-enriched, but it should be noted that not only different methods but also different species (human and mouse) and different statistical criteria were used to identify retina-enriched genes in each of the studies. Known photoreceptor genes were excluded from our analysis, both because they are generally the easiest to detect and because they were not included in two of the studies. 1, 4 In addition, because we used Unigene clusters to compare findings across the different studies, only known genes and ESTs that were assigned to such clusters were compared. Table 8A shows the number of genes that were identified in two or more studies. The degree of overlap ranged from 23.9% (percent of genes from Sharon et al. 3 that were identified by us as well) to 0% (no overlap between Blackshaw et al. 1 and Stohr et al. 4 ). Overall, the present study showed more overlap with the other studies than any of the other studies showed with each other. We identified 44 retina-enriched genes that were also identified in one of the other studies, and three genes that were identified in two of them (Table 8B) . No genes were identified that were shared by two other studies but not by ours, and, perhaps surprisingly, there were not any genes that were identified as differentially expressed in all four studies.
DISCUSSION
Several recent high-throughput studies have focused on identifying retina-enriched genes.
1-8 Blackshaw et al. 1 used SAGE analyses to identify 264 novel mouse rod-enriched or -specific genes. Sharon et al. 3 used SAGE to obtain gene expression profiles of two human retinas. By comparing their results to 100 nonocular SAGE libraries, they identified 89 retina-specific or -enriched SAGE tags. 3 In another recent study, Stohr et al. 4 used EST data mining to identify several hundred retina-enriched or -specific Unigene clusters. The expression patterns of ESTs from 180 of these Unigene clusters were then assessed by RT-PCR, and 39 retina-specific ESTs were identified. 4 However, because the RT-PCR used was not quantitative, it is possible that additional ESTs from the group of 180 may exhibit a retina-enriched expression pattern.
We have constructed a cDNA microarray designed for analysis of human retinal gene expression under normal and pathologic conditions. As an initial use for the microarray, we have applied it to characterize gene expression pattern differences between retina, another central nervous system-derived tissue (cerebral cortex) and liver. This comparison enabled the identification of more than 100 novel retina-enriched genes, as well as a large group of known genes that were not previously reported to have a retina-enriched expression pattern. Several of these known genes may play important roles in the physiology of the retina. For example, thrombomodulin, an endothelial cell surface glycoprotein that forms a complex with thrombin and converts it into a potent anticoagulant, was previously detected in chorioretinal blood vessels and in the anterior eye segment. 24, 25 The finding of its preferential expression in the retina suggests a possibly significant role in maintaining retinal and choroidal blood flow.
Both bioinformatic and experimental data support the validity of the microarray-derived expression results. First, the microarrays correctly identified multiple known retina-en- The number in parenthesis is the number of genes reported in each study as retina-enriched (either known or novel genes) with an assigned Unigene cluster and that were not previously characterized as retina enriched. Data represent the number of genes found to be in common between the two studies in a pair-wise comparison.
riched genes. Second, the bioinformatic analysis we used, based on the SAM algorithm, is tested for internal consistency in the microarray data by looking for expression differences that were consistent across the five retina samples compared with the brain and liver samples. 19 Third, the microarray analysis identified 47 genes that have been reported recently as retina-enriched by other investigators. 1, 3, 4 Fourth, we confirmed the microarray findings for 10 of the newly identified differentially expressed genes and ESTs with an independent experimental method, QPCR. Consistent with previous reports, the QPCR data in fact suggest that the microarray results tended to underestimate the identified differential expression patterns. 22, 23, 26 Fifth, analysis of available databases revealed that ESTs corresponding to the microarray identified retinaenriched genes were identified in fewer tissue sources than the overall clones represented on the array, which in turn were present in fewer tissues than sequences randomly selected from the genome. Last, clustering of the microarray data by two different algorithms successfully identified the five retina samples as being distinct from the liver and cortex samples.
Several caveats about our study should be acknowledged. First, although the retina custom microarray contains a substantial representation of the genes (both novel and known) that have been identified in retina cDNA libraries, additional retina-enriched genes not represented on the microarray are likely to exist. Second, we have studied whole retinas, but because the retina contains approximately 50 different cell types, 27 conclusions regarding the gene expression patterns in particular retinal cell types cannot be directly drawn from our study. This problem may be addressed by expression profiling 28, 29 or single-cell isolation methods 30 (Wahlin et al., manuscript in preparation). A challenge in using these methods for microarray studies, however, is that they require amplification, a process that potentially introduces significant bias to the analysis.
Although there was considerable overlap between our microarray results and the previous SAGE and bioinformatic studies, 1, 3, 4 it seems significant that many of the novel retinaenriched genes were identified by only one of the studies. Several factors may account for this surprising finding. Species differences in gene expression pattern may contribute to the relatively small overlap between the mouse SAGE study 1 and the human SAGE, EST data mining, and microarray studies. 3, 4 As an example of potential species differences, we have identified several genes that are highly expressed in bovine and human RPE, but only minimally if at all in murine RPE, as well as a human and bovine retinal transcription factor that appears not to even exist in the mouse genome (Wang et al., manuscript submitted). However, given the major structural and functional similarities between murine and human retina, species differences probably account for only a small fraction of the observed expression profile differences. A more likely factor is the probable existence of a large number of unknown retina-enriched genes, together with the likely possibility that each method and approach is sampling only a limited and partially overlapping subset of this larger set. Additional microarray, SAGE, and bioinformatic studies, together with proteomic and other approaches, should eventually more definitively define the unique expression profiles of the murine and human retina.
